Development of a plasma-derived polyclonal antibody-based covid-19 therapeutic

Ended Awarded Last action

Contract number
75A50120F33006
Awardee
Awarding agency
Obligated
$15,477,804

Award facts

Contract value 67% obligated
  • $15,477,803.68 Current, with exercised options
  • $23,109,340.68 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Baltimore, MD 21224, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00006 · The purpose of this bilateral modification is to deobligate $0.32 in unexpended funds from clin 001. -$0
Other Administrative Action P00005 · The purpose of this unilateral modification is to update the task order contracting officer to christopher weaver. $0
Terminate for Convenience P00004 · Terminate for convenience of the government $0
Supplemental Agreement for work within scope P00003 · This is no cost modification is to change the base period of performance on task order 6 under emergent contract HHSO100201200004I from the current end date… $0
Funding Only Action P00001 · Add funds to cover plasma acquisition costs for the manufacture of anti-sars-COV-2 hyperimmune globulin. $946,003
Original award $14,531,801

About this award

Written by GovTribe AI ·

This is a $23,109,340.68 cost-plus-fixed-fee delivery order awarded to Emergent Manufacturing Operations Baltimore LLC, a for-profit limited liability company manufacturer, by the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services. The contract is for the development of a plasma-derived polyclonal antibody-based COVID-19 therapeutic, under the Centers for Innovation in Advanced Development and Manufacturing program. No set-aside designation was used. Emergent has received previous contract awards from the Department of Health and Human Services for expanding manufacturing capacity and developing medical countermeasures.

Quick answers

Who was awarded contract 75A50120F33006?

75A50120F33006 was awarded to Emergent Manufacturing Operations Baltimore LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on April 2, 2020.

How much is contract 75A50120F33006 worth?

The government has obligated $15,477,804 on 75A50120F33006. Its potential value, with all options, is $23,109,341.

Is contract 75A50120F33006 an order under another contract?

Yes. 75A50120F33006 is a delivery order under HHSO100201200004I, an indefinite delivery contract.

Was contract 75A50120F33006 competed?

The extent of competition for 75A50120F33006 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login